Menopause Diagnosis: Clinical Assessment Without Routine Laboratory Testing
In women over 45 years with 12 consecutive months of amenorrhea, menopause is diagnosed clinically without requiring hormonal testing or imaging 1.
Standard Clinical Diagnosis
The diagnosis of menopause is fundamentally a retrospective clinical diagnosis based on:
- 12 months of consecutive amenorrhea in women over 45 years of age
- Compatible symptoms (vasomotor symptoms, sleep disturbance, mood changes, vaginal dryness)
- No other pathological cause for amenorrhea 1
No hormonal assays (FSH, estradiol) or pelvic imaging are indicated for diagnosing menopause in straightforward cases 1. This represents the consensus approach from multiple international societies including the International Menopause Society and European Menopause and Andropause Society.
Special Clinical Situations Requiring Modified Approach
Women Using Hormonal Contraception
For women on combined oral contraceptives, progestin-only pills, implants, or levonorgestrel IUDs:
- Hormonal assays and ultrasound are NOT recommended to diagnose menopause or decide when to stop contraception 1
- Recommended strategy: Discontinue oral contraception, remove implant or LNG-IUD, then follow clinically for amenorrhea (expert consensus) 1
- The only way to determine menopausal status is interruption of hormonal contraception and observation 2
Post-Hysterectomy Women
Without evaluable amenorrhea as a clinical marker:
- Repeat FSH ≥40 mIU/mL combined with estradiol <20 pg/mL, measured at least 3 months apart, can provide diagnostic orientation toward menopausal status 1
- This is the one situation where hormonal testing has clinical utility, though it remains imperfect
Important caveat: Even in low-weight women (BMI <18.5), 30% of those clinically classified as menopausal had FSH levels below the diagnostic threshold (<25 mIU/mL), highlighting potential for misclassification when relying on laboratory values 3.
Post-Cancer Treatment
In women who received gonadotoxic chemotherapy or radiation:
- The standard 12-month amenorrhea criterion cannot reliably diagnose menopause 1
- No examination can definitively confirm menopausal status in this population (expert opinion) 1
- For breast cancer patients on hormonal contraception at diagnosis, assume non-menopausal status by default when selecting cancer hormone therapy if menopausal status is unknown 1
What NOT to Do
Common pitfalls to avoid:
- Do not routinely order FSH or estradiol levels in women with straightforward 12-month amenorrhea 1
- Do not rely on single FSH measurements, as levels fluctuate during the perimenopausal transition 4
- Do not assume amenorrhea of less than 12 months confirms menopause—menstrual periods can resume after several months of amenorrhea 2
- Do not use hormonal assays to time contraception cessation in women on hormonal birth control 1
Perimenopausal Transition Recognition
While not "menopause" per se, subtle changes in menstrual cycle length reflect significant hormonal shifts:
- Inhibin B and FSH levels change significantly even with subtle bleeding pattern changes during early transition 4
- Clinical observation of cycle length changes is more practical than hormonal monitoring for identifying the menopausal transition 4
The Bottom Line
Menopause diagnosis is clinical, not laboratory-based. Age-appropriate amenorrhea for 12 consecutive months is sufficient. Reserve hormonal testing only for post-hysterectomy patients where clinical assessment is impossible, and even then, interpret results cautiously given the high rate of non-diagnostic values in certain populations 1, 3.